Drs Milner, Dalal, and Ligon discuss hematopoietic stem cell transplant in children with severe aplastic anemia, graft failure risk factors in children receiving hematopoietic cell transplant for non-malignant disorders, and the use of mediports for CAR T-cell infusion.
Welcome to OncLive On Air®! I’m your host today, Ashling Wahner.
OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
In today’s episode, we had the pleasure of speaking with Jordan B. Milner, MD; Mansi Dalal, MD; and John Ligon, MD, about findings from 3 abstracts presented at the 2023 Transplantation & Cellular Therapy Meetings.
Dr Milner is a clinical assistant professor in the Department of Pediatric Hematology Oncology at the University of Florida College of Medicine in Gainesville, Florida, where Dr Dalal is a clinical assistant professor in the Department of Pediatrics and Dr Ligon is an assistant professor in the Department of Pediatrics.
In our exclusive interview, Dr Milner shared findings from a study, coauthored by Drs Dalal and Ligon, on hematopoietic stem cell transplant in children with severe aplastic anemia. Additionally, Dr Dalal explained the results of a study on graft failure risk factors in children receiving hematopoietic cell transplant for non-malignant disorders. Finally, Dr Ligon discussed findings from a study investigating the use of mediports for CAR T-cell infusion.
That’s all we have for today! Thank you for listening to this episode of OncLive On Air®. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.
For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters. To read additional coverage from the meeting, visit https://www.onclive.com/conference/tct.
OncLive® is also on social media. On Twitter, follow us at @OncLive and @OncLiveSOSS. On Facebook, like us at OncLive and OncLive State of the Science Summit and follow our OncLive page on LinkedIn.
If you liked today’s episode of OncLive On Air®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!
Thanks again for listening to OncLive On Air®.
*OncLive On Air® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.